Cargando…

DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3

Pre–B and pre–T lymphocytes must orchestrate a transition from a highly proliferative state to a quiescent one during development. Cyclin D3 is essential for these cells’ proliferation, but little is known about its posttranslational regulation at this stage. Here, we show that the dual specificity...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Benjamin J., Bhansali, Rahul, Diebold, Lauren, Cook, Daniel E., Stolzenburg, Lindsay, Casagrande, Anne-Sophie, Besson, Thierry, Leblond, Bertrand, Désiré, Laurent, Malinge, Sébastien, Crispino, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451127/
https://www.ncbi.nlm.nih.gov/pubmed/26008897
http://dx.doi.org/10.1084/jem.20150002
_version_ 1782374099353337856
author Thompson, Benjamin J.
Bhansali, Rahul
Diebold, Lauren
Cook, Daniel E.
Stolzenburg, Lindsay
Casagrande, Anne-Sophie
Besson, Thierry
Leblond, Bertrand
Désiré, Laurent
Malinge, Sébastien
Crispino, John D.
author_facet Thompson, Benjamin J.
Bhansali, Rahul
Diebold, Lauren
Cook, Daniel E.
Stolzenburg, Lindsay
Casagrande, Anne-Sophie
Besson, Thierry
Leblond, Bertrand
Désiré, Laurent
Malinge, Sébastien
Crispino, John D.
author_sort Thompson, Benjamin J.
collection PubMed
description Pre–B and pre–T lymphocytes must orchestrate a transition from a highly proliferative state to a quiescent one during development. Cyclin D3 is essential for these cells’ proliferation, but little is known about its posttranslational regulation at this stage. Here, we show that the dual specificity tyrosine-regulated kinase 1A (DYRK1A) restrains Cyclin D3 protein levels by phosphorylating T283 to induce its degradation. Loss of DYRK1A activity, via genetic inactivation or pharmacologic inhibition in mice, caused accumulation of Cyclin D3 protein, incomplete repression of E2F-mediated gene transcription, and failure to properly couple cell cycle exit with differentiation. Expression of a nonphosphorylatable Cyclin D3 T283A mutant recapitulated these defects, whereas inhibition of Cyclin D:CDK4/6 mitigated the effects of DYRK1A inhibition or loss. These data uncover a previously unknown role for DYRK1A in lymphopoiesis, and demonstrate how Cyclin D3 protein stability is negatively regulated during exit from the proliferative phases of B and T cell development.
format Online
Article
Text
id pubmed-4451127
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-44511272015-12-01 DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3 Thompson, Benjamin J. Bhansali, Rahul Diebold, Lauren Cook, Daniel E. Stolzenburg, Lindsay Casagrande, Anne-Sophie Besson, Thierry Leblond, Bertrand Désiré, Laurent Malinge, Sébastien Crispino, John D. J Exp Med Article Pre–B and pre–T lymphocytes must orchestrate a transition from a highly proliferative state to a quiescent one during development. Cyclin D3 is essential for these cells’ proliferation, but little is known about its posttranslational regulation at this stage. Here, we show that the dual specificity tyrosine-regulated kinase 1A (DYRK1A) restrains Cyclin D3 protein levels by phosphorylating T283 to induce its degradation. Loss of DYRK1A activity, via genetic inactivation or pharmacologic inhibition in mice, caused accumulation of Cyclin D3 protein, incomplete repression of E2F-mediated gene transcription, and failure to properly couple cell cycle exit with differentiation. Expression of a nonphosphorylatable Cyclin D3 T283A mutant recapitulated these defects, whereas inhibition of Cyclin D:CDK4/6 mitigated the effects of DYRK1A inhibition or loss. These data uncover a previously unknown role for DYRK1A in lymphopoiesis, and demonstrate how Cyclin D3 protein stability is negatively regulated during exit from the proliferative phases of B and T cell development. The Rockefeller University Press 2015-06-01 /pmc/articles/PMC4451127/ /pubmed/26008897 http://dx.doi.org/10.1084/jem.20150002 Text en © 2015 Thompson et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Article
Thompson, Benjamin J.
Bhansali, Rahul
Diebold, Lauren
Cook, Daniel E.
Stolzenburg, Lindsay
Casagrande, Anne-Sophie
Besson, Thierry
Leblond, Bertrand
Désiré, Laurent
Malinge, Sébastien
Crispino, John D.
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
title DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
title_full DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
title_fullStr DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
title_full_unstemmed DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
title_short DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
title_sort dyrk1a controls the transition from proliferation to quiescence during lymphoid development by destabilizing cyclin d3
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451127/
https://www.ncbi.nlm.nih.gov/pubmed/26008897
http://dx.doi.org/10.1084/jem.20150002
work_keys_str_mv AT thompsonbenjaminj dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT bhansalirahul dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT dieboldlauren dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT cookdaniele dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT stolzenburglindsay dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT casagrandeannesophie dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT bessonthierry dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT leblondbertrand dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT desirelaurent dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT malingesebastien dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3
AT crispinojohnd dyrk1acontrolsthetransitionfromproliferationtoquiescenceduringlymphoiddevelopmentbydestabilizingcyclind3